secwatch.observer — SEC 8-K summary
======================================

Issuer:     Olema Pharmaceuticals, Inc. (OLMA)
CIK:        0001750284
Form:       8-K
Filed at:   2026-05-01T23:59:59+00:00
Accession:  0001193125-26-201751
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 1.01, 2.03
LLM model:  deepseek-v4-flash:cloud@v2

Olema enters 7-year lease for ~38K sq ft corporate HQ in San Francisco
----------------------------------------------------------------------

- Lease with KR Oyster Point II, LLC for 38,176 sq ft on 4th and 5th floors.
- Base rent for Phase I (25,048 sq ft) is $12,361,188 over initial term.
- Base rent for Phase II (13,128 sq ft) is $6,145,463.76 over initial term.
- Initial term 7 years; one-time termination option at 60 months with $1,716,240.96 fee.
- Cash security deposit of $427,546.80 required; move-in expected by December 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1750284/000119312526201751/0001193125-26-201751-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1750284/000119312526201751/olma-20260427.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-201751

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer